Concepedia

Priya Retna

PR

Statistics

Publications

4

Citations

174

H-Index

4

Active since

2018

Affiliations

Experimental Drug Development Centre(Current)

National University of Singapore

Duke-NUS Medical School

Agency for Science, Technology and Research

Priya Retna is an author at Experimental Drug Development Centre specializing in oncology, drug discovery, and pharmacy.

Publications per year

2018–2021

4

Publications

4

Strategic Design of Catalytic Lysine‐Targeting Reversible Covalent BCR‐ABL Inhibitors**

David Quach, Guanghui Tang, Jothi Anantharajan et al. · Angewandte Chemie International Edition · 2021 · 78 citations

, , +16

Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia

Haiyan Yang, Lohitha Rao Chennamaneni, Melvyn Wai Tuck Ho et al. · Journal of Medicinal Chemistry · 2018 · 54 citations · Full text

, , +17

Discovery of Irreversible Inhibitors Targeting Histone Methyltransferase, SMYD3

Chuhui Huang, Si Si Liew, Grace Lin et al. · ACS Medicinal Chemistry Letters · 2019 · 30 citations · Full text

, , +14

Stepwise Evolution of Fragment Hits against MAPK Interacting Kinases 1 and 2

Jacek Kwiatkowski, Shermaine Pang, Nur Huda Binte Ahmad et al. · Journal of Medicinal Chemistry · 2020 · 12 citations

, , +13

1–4 of 4